Area expert weighs in on FDA’s accelerated approval for new Alzheimer’s drug

Published: Jan. 6, 2023 at 6:33 PM EST
Email This Link
Share on Pinterest
Share on LinkedIn

FORT WAYNE, Ind. (WPTA) - Friday afternoon, the FDA granted accelerated approval for a new Alzheimer’s drug called Lecanemab. FDA officials say soon, it should receive conditional approval and then full approval later in the year.

It could be a major game-changer for patients who are newly-diagnosed and for their caregivers.

Linda Jackson spoke with an area expert for more perspective.

Latest News

Latest News